Some of the content on this page has been created using generative AI.
What is it about?
The article discusses the role of basal hyperinsulinemia, which is the inappropriate secretion of excess insulin by beta-cells in response to perceived nutrient excess. The authors propose a testable hypothetical mechanism to explain the role of lipids and ROS in basal hyperinsulinemia and how they differ from glucose-stimulated insulin secretion (GSIS). The model centers on redox control, via ROS, and S-acylation-mediated trafficking via LC-CoA. The article explains how excessive calorigenic nutrients increase mitochondrial ROS production by the electron transport chain (ETC), whether the fuel is glucose, fat, or amino acids. The authors propose that failure to either increase or decrease ROS or LC-CoA appropriately, by non-nutrient environmental chemicals, will disturb beta-cell function. The article highlights the unique characteristic of beta-cells, which is their relatively low expression of antioxidant enzymes, rendering beta-cells susceptible to oxidative damage on the one hand but allowing ROS levels to remain elevated longer and move from mitochondria to cytosol to serve as a signal of excess. The authors also discuss the essential role of lipids in GSIS and how intracellular lipids are essential even when glucose is the only fuel provided.
Featured Image
Why is it important?
The research is important because it presents a testable hypothetical mechanism that explains the role of lipids and reactive oxygen species (ROS) in basal hyperinsulinemia, which is a condition where the pancreas produces too much insulin. This is a problem caused by environmental toxins posing as fuels. This mechanism centers on redox regulation and S-acylation-mediated trafficking via long-chain acyl-CoA esters (LC-CoA). Understanding the role of these factors is crucial for developing new therapies for diseases like obesity and type 2 diabetes, which are characterized by insulin resistance and impaired insulin responses to high glucose. Key Takeaways: 1. Basal hyperinsulinemia is an adaptation to sustained real or perceived nutrient excess that only manifests as a disease when the excess demand can no longer be met by an overworked beta-cell. 2. The research proposes a testable hypothetical mechanism that explains the role of lipids and ROS in basal hyperinsulinemia, which differs from glucose-stimulated insulin secretion (GSIS). 3. The mechanism centers on redox regulation via ROS and S-acylation-mediated trafficking via LC-CoA. 4. Lipids and ROS play essential roles in basal secretion, promoting storage in response to the perception of nutrient excess and stimulating insulin-mediated adipocyte TG synthesis. 5. Inhibitory roles of lipids may lead to appropriate diminished secretion in starvation despite the presence of elevated lipids.
AI notice
Read the Original
This page is a summary of: What Regulates Basal Insulin Secretion and Causes Hyperinsulinemia?, Diabetes, September 2021, American Diabetes Association,
DOI: 10.2337/dbi21-0009.
You can read the full text:
Contributors
The following have contributed to this page







